DUPHAT 2026 Concludes with Approximately AED10.3 Billion in Trade Deals
Fahad Shabbir (@FahadShabbir) | August 27, 2026
DUBAI, (UrduPoint / Pakistan Point News / WAM – 27th Aug, 2026) The 31st edition of the
Dubai International Pharmaceuticals and Technologies Conference and Exhibition – DUPHAT 2026 concluded successfully today at
Dubai World Trade Centre, marking three days of high-level discussions, scientific exchange, and industry engagement.
The event recorded approximately AED10.3 billion in direct and indirect trade deals over the three days, further highlighting its role as a leading platform for advancing the pharmaceutical sector and fostering business opportunities.
The event brought together leading experts, healthcare professionals, researchers, and decision-makers from across the pharmaceutical and healthcare sectors to explore the future of pharmacy and the evolving role of pharmacists amid rapid advances in artificial intelligence, precision medicine, and biotechnology.
Discussions also focused on medication safety, pharmacy education, research, and stronger collaboration across the healthcare ecosystem, with an emphasis on transforming scientific knowledge and technological innovation into practical solutions that improve patient outcomes and strengthen healthcare delivery.
Amb. Prof. Abdulsalam AlMadani, Chairman of DUPHAT and DUPHAT International Scientific Council (DISC) and Roving Ambassador of the Parliamentary Assembly of the Mediterranean (PAM) for the GCC Region, stated:
"DUPHAT 2026 once again demonstrated the strength and growth potential of the pharmaceutical sector, bringing together leading experts, healthcare professionals, researchers, industry leaders, and decision-makers from around the world to exchange knowledge, explore emerging technologies, and build meaningful partnerships."
The significant trade deals recorded during the edition reflect growing confidence in the pharmaceutical and healthcare sectors and reinforce Dubai’s position as a global hub for business, innovation, and scientific collaboration, in line with the UAE’s vision to advance healthcare and foster a more innovative and sustainable health ecosystem.
Ultimately, DUPHAT’s success goes beyond numbers. Its greatest impact lies in turning knowledge into action, innovation into impact, and collaboration into sustainable progress in healthcare.”
He added, “As the pharmaceutical sector enters a new era shaped by artificial intelligence, precision medicine, biotechnology, and digital transformation, we must ensure that these advances remain firmly centred on patient needs, safety, and better health outcomes.
DUPHAT 2026 has provided an important platform for dialogue, and the recommendations emerging from the conference will contribute to shaping a more innovative, responsible, and patient-centred future for pharmacy.”
Dr Farida Alkhaja, Chair of the Scientific Committee of DUPHAT 2026, stated that the most important message emerging from the conference is… (the rest of the text is not fully provided, but it can be assumed to continue with insights from Dr. Alkhaja)
